Study finds 2 competing opioid treatments have similar outcomes; GOP tax bill includes repeal of the ACA's individual mandate; and a study finds a correlation between screen time and depression in teenage girls.
A recent study has found that 2 of the main treatments for opioid addiction, Vivitrol and Suboxone, have similar outcomes. According to The New York Times, researchers found that 52% of those who started on Vivitrol, a monthly shot that blocks the effects of opioids, relapsed during the 24-week study. For those who started on Suboxone, a daily strip that dissolves on the tongue and contains a mild opioid that helps minimize withdrawal symptoms and cravings, there was a 56% relapse rate.
On Tuesday, Senate Republican leaders announced that their tax bill will include a provision repealing the Affordable Care Act (ACA)'s individual mandate, reported The Washington Post. The mandate requires Americans to purchase health insurance or else pay a fine. According to the Congressional Budget Office (CBO), the repeal of the mandate would free up over $300 billion in government funding over the next decade that Republicans can utilize to finance their proposed tax cuts, but it would result in 13 million fewer people having health insurance. CBO also estimated that repealing the mandate would increase insurance premiums by roughly 10% for many Americans.
According to NPR, a recent study has found that increased hours spent on computers, cell phones, and other electronic devices might have contributed to the increase in symptoms of depression and suicidal thoughts in teens, especially girls, over the last several years. Reponses to national surveys showed that between 2010 and 2015, the proportion of teen girls who answered “yes” to 3 or more questions about having symptoms of depression increased from 16% to 22%.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen